Target intelligence / Profile preview

TOLLIP divergent transcript (TOLLIP-DT)

Target
TOLLIP-DT
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

TOLLIP divergent transcript (TOLLIP-DT, also known as TOLLIP-AS1 or CTD-2245O6.1) is a human long non-coding RNA (lncRNA) gene located at chromosome 11p15.5 and transcribed in the antisense direction relative to the *TOLLIP* gene[4][10]. As an antisense lncRNA, TOLLIP-DT is involved in the regulation of its sense partner gene (TOLLIP) likely through chromatin modification, transcriptional interference, or recruitment of transcriptional and splicing factors, which is typical of natural antisense transcripts[3][10]. Functional genomic data show TOLLIP-DT is differentially expressed in several cancers and correlates with cancer stage and subtype[10], but its precise cellular functions and clinical relevance are still being elucidated. It is not considered a therapeutic target such as a receptor or enzyme, nor are specific drugs known to modulate it directly.

Other names
TOLLIP-AS1CTD-2245O6.1TOLLIP antisense RNA 1 (head to head)TOLLIP-DT
02

Biological functions

Regulation of gene expression (cis/trans effects)Epigenetic regulationPotential enhancer-like activityInteraction with transcription factors and splicing factors
03

Disease associations

Cancer (e.g., kidney renal clear cell carcinoma, cholangiocarcinoma, kidney chromophobe carcinoma)Other (implicated via gene regulation but disease links remain emerging)
04

Biomarkers

Potential biomarker for cancer differentiation and stagingnot established in clinical use

Beyond the preview

Go deeper on TOLLIP divergent transcript (TOLLIP-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TOLLIP divergent transcript (TOLLIP-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call